Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Current Pharmaceutical Design|July 14, 2007
Potential prophylactic and therapeutic vaccines for HSV infectionsSrividya Ramachandran, Paul R KinchingtonViruses|December 4, 2012
Role of lymphocytic choriomeningitis virus (LCMV) in understanding viral immunology: past, present and futureXin Zhou, Srividya Ramachandran, Margaret Mann, et al.Virology|July 16, 2008
Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promotersSrividya Ramachandran, Jared E Knickelbein, Christina Ferko, et al.Journal of Virology|June 25, 2010
Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alters neurovirulence and inhibits the gB-CD8+ T-cell response in the trigeminal ganglionSrividya Ramachandran, Katherine A Davoli, Michael B Yee, et al.Plos Pathogens|December 6, 2017
Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cellsBenjamin R Treat, Sarah M Bidula, Srividya Ramachandran, et al.Plos Pathogens|May 23, 2012
Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesisVolker Fensterl, Jaime L Wetzel, Srividya Ramachandran, et al.Contemporary Clinical Trials|August 14, 2016
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Christopher S Coffey, Merit E Cudkowicz, et al.Pageof 1